Industry Trends Oxygen therapy devices, sleep diagnostic devices and respiratory disposables, are expected to be the fastest-growing segments in the European anesthesia, respiratory and sleep management device market. As an alternative to the centralized delivery of concentrated oxygen, devices that allow patients to generate their own oxygen at home have played a significant role. This
Insurance reimbursement rates, including those of Medicaid and Medicare, have shifted away from covering highly expensive type I tests in favor of HST, which are less expensive. This has led to a decline in the market for type I devices. Recent annual declines have been more modest, but they are expected to become more pronounced
Overall, the market for sleep therapy interfaces is set to grow at a faster rate than the positive airway pressure device market. Specifically driving growth in that market is the full-face and nasal pillow options, as they offer greater patient comfort and have grown quite drastically in recent years. On the other hand, within the
In 2021, the U.S. anesthesia, respiratory and sleep therapy market size is estimated to reach nearly $5.5 billion, with the Anesthesia Information Management System market expected to experience the fastest growth. In spite of COVID19, the U.S. market size is projected to increase over the forecast period to exceed $6.6 billion in 2027. Currently, over
In 2021, the Europe anesthesia, respiratory and sleep therapy devices market size is estimated to reach €1.8 billion, with the Sleep Diagnostic Device market expected to experience the fastest growth. In spite of COVID19, the EU market size is projected to increase over the forecast period to exceed $1.8 billion in 2027. Currently, over 35%
The total market for sleep apnea diagnostic devices consists of four types of devices: type I (full attended PSG), type II (portable unattended PSG), type III (HST with a minimum of four channels) and type IV (HST with a minimum of three channels). The longest standing test type, the golden standard has been
type I tests which are conducted in a hospital or lab setting and require attendance of a lab technician or doctor. In terms of overall market total for the market for sleep diagnostic tests, type I devices represented approximately 63% of the market in 2016. In terms of sheer procedure volume, these devices are still used the most in the market; however, this is set to shift in the near future.
Obstructive sleep apnea is a respiratory disorder wherein an individuals airway is obstructed during sleep as muscles relax and the airway walls and tissue collapse. The resulting asphyxia arouses the individual from the deeper stages of sleep so that normal breathing can be restored. It is this disruption of regular sleep rhythms that causes the negative symptoms associated with sleep apnea. During these events (termed apneic events), breathing ceases long enough to allow several normal breaths to be missed. In order to be considered an apneic event, a ten second interval between breaths and neurological arousal and/or blood oxygen desaturation are required. In most cases, the sufferer is unaware of experiencing such an event at the time, often simply falling back asleep afterwards.
The overall market for obstructive sleep apnea (OSA) therapy devices in Europe is segmented into two main device groups: PAP machines including CPAP, BiPAP and APAP variations, and facial interfaces including nasal masks, full-face masks and nasal/pillow alternative interfaces masks.
The total market for sleep apnea diagnostic devices consists of three types of devices: polysomnography (PSG) devices, home respiratory polygraphy devices and home sleep testing screening devices. There has been a growing awareness over the past decade of obstructive sleep apnea (OSA) and the costs of leaving the condition untreated. Prior to 2009, sleep labs were opened and expanded resulting in rapid expansion of the market for sleep diagnostic devices. However, diagnostic capacity is no longer expanding and the market is now primarily composed of replacement sales.